Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs-Reference-Cited by-同舟云学术

Preventive therapy for tuberculosis in rheumatological patients undergoing therapy with biological drugs

Published:2018-06-03 Issue:6 Volume:16 Page:501-512
ISSN:1478-7210
Container-title:Expert Review of Anti-infective Therapy
language:en
Short-container-title:Expert Review of Anti-infective Therapy

Author:

Goletti Delia¹^ORCID,Petrone Linda¹,Ippolito Giuseppe²,Niccoli Laura³,Nannini Carlotta³,Cantini Fabrizio³

Affiliation:

1. Translational Research Unit, Department of Epidemiology and Preclinical Research, “L. Spallanzani” National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy

2. Scientific Direction, “L. Spallanzani” National Institute for Infectious Diseases (INMI), IRCCS, Rome, Italy

3. Department of Rheumatology, Hospital of Prato, Prato, Italy

Funder

TBVAC2020

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Microbiology (medical),Microbiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/14787210.2018.1483238

Reference139 articles.

1. The Global Burden of Latent Tuberculosis Infection: A Re-estimation Using Mathematical Modelling

2. Tumor necrosis factor-α is required in the protective immune response against mycobacterium tuberculosis in mice

3. Tuberculosis

4. Contact investigation for tuberculosis: a systematic review and meta-analysis

5. Risk Factors for Tuberculosis in HIV-lnfected Persons

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment of psoriasis with biologic and non‐biologic targeted therapies in patients with latent tuberculosis infection or at risk for tuberculosis disease progression: Recommendations from a SPIN‐FRT expert consensus;Journal of the European Academy of Dermatology and Venereology;2024-08-16

2. Consenso para la gestión de riesgo en la prescripción de terapias biológicas o de antirreumáticos sintéticos con blanco dirigido: Asociación Colombiana de Reumatología 2023;Revista Colombiana de Reumatología;2024-04

3. Screening, prophylaxis, and challenges: Tumor necrosis factor inhibitors and latent tuberculosis infection nexus in rheumatology;International Journal of Rheumatic Diseases;2023-12-07

4. Alternative biomarkers of tuberculosis infection in patients with immune-mediated inflammatory diseases;Frontiers in Medicine;2023-11-23

5. Research tests for the diagnosis of tuberculosis infection;Expert Review of Molecular Diagnostics;2023-08-10